POCT Haemoglobin
[POCT Haemoglobin]
EPTIS Ringversuch Nr. 142674 | Letze Änderung 2024-05-22 | URL: https://www.eptis.bam.de/pts142674 https://www.eptis.bam.de/pts142674
Name des Anbieters | |||||||
Name des Anbieters | Weqas Weqas | ||||||
Ansässig in | United Kingdom | ||||||
Sprache(n) | |||||||
Anmerkungen | Haemoglobin (Hb) is the iron containing oxygen transport metalloprotein in red blood cells and is one of the most common laboratory tests performed. The test is used to detect and measure the severity of anaemia, monitor the response to treatment, and help make decisions about blood transfusions. Iron deficiency Anaemia is defined as a Hb < 130 g/L in men aged over 15 years, and <120 g/L in non-pregnant women aged over 15 years or children aged 12–14 years, and < 110 g/L during pregnancy. An Hb level of 110 g/L or more appears adequate in the first trimester, and a level of 105 g/L appears adequate in the second and third trimesters. Postpartum a Hb < 100 g/L is consistent with anaemia. POCT Hb is usually undertaken when a fast turnaround time is needed for immediate therapeutic decisions and are often used in the identification and management of anaemia in the perioperative pathway. POCT Hb can be measured on a blood gas analyser (BGA), and on specific POCT devices. The material is purified stroma free bovine haemolysate, requiring no prior preparation. Two samples are distributed bimonthly, with a minimum of 12 samples distributed over the year covering a wide, clinically relevant range. The samples consist of a panel of 5 samples distributed on a number of occasions over that period, which are used to assess both the user and device performance, including linearity, bias, within and between batch imprecision. Key Features: - Ready to use samples in dropper bottles, no need for reconstitution. - Panel of samples distributed covering the pathological range. - Programme assesses both user and device performance, including linearity, bias, within and between batch imprecision. - Scoring based on Milan Model 3 performance specification. For more information: https://www.weqas.com/services/poct-eqa/poct-haemoglobin/ or contact@weqas.com | ||||||
Klassifizierung | |||||||
Produktgruppen |
Health care / medical devices
|
||||||
Prüfgebiete |
Medical analysis
|
||||||
Technische Einzelheiten | |||||||
|
|||||||
Ringversuchsziele | |||||||
Zielgruppe des Ringversuchs | The POCT Hb EQA Programme is specifically designed for the quantitative assay of Hb using a POCT Hb device, for Hb measurement using a BGA please refer to our Blood Gas/Co-oximetry EQA Programme. | ||||||
Relevante Rechtsvorschriften oder Normen | Accreditation by UKAS on the basis of ISO/IEC 17025, 17043 and 15195 | ||||||
Weitere Ziele | validation of testing methods | ||||||
Teilnehmerzahl | |||||||
Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch UKAS auf der Grundlage von ISO/ IEC 17043 |
||||||
Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | |||||||
Kosten | |||||||
Teilnahmegebühr | https://www.weqas.com/participantzone/subscription-charges/ | ||||||
Regelmässig durchgeführt | Ja (Frequency: Bimonthly. Samples: 2 x 1.0mL. ) | ||||||
Der Ringversuch wird durchgeführt seit | 2007 | ||||||
Kontaktdaten des Anbieters | |||||||
Anbieter | Kontaktperson | ||||||
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Telefon: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Telefon: 44 (0) 29218 32884 Fax: E-Mail: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |